AYTU BIOSCIENCE, INC (77) | Business Operations (11)
Browse by Subcategory
Recent Contracts
-
Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022
(Filed With SEC on May 16, 2022)
-
Controlled Equity OfferingSM Sales Agreement, dated June 4, 2021, by and between Aytu BioPharma, Inc. and Cantor Fitzgerald & Co
(Filed With SEC on June 7, 2021)
-
Indemnification Agreement between Aytu BioPharma, Inc. and Gerald McLaughlin, dated March 19, 2021
(Filed With SEC on May 17, 2021)
-
Form of Aytu Stockholder Voting Agreement
(Filed With SEC on December 10, 2020)
-
Placement Agency Agreement, dated October 11, 2019
(Filed With SEC on October 15, 2019)
-
Independent Contractor Services Agreement dated as of May 1, 2019, by and between Aytu BioScience, Inc. and Averaden, LLC
(Filed With SEC on May 2, 2019)
-
Termination Agreement, dated June 29, 2021 by and between Aytu BioPharma, Inc. and Avrio Genetics, LLC
(Filed With SEC on September 28, 2021)
-
Indemnification Agreement between Aytu BioPharma, Inc. and Beth P. Hecht, dated March 19, 2021
(Filed With SEC on May 17, 2021)
-
Form of Neos Stockholder Voting Agreement
(Filed With SEC on December 10, 2020)
-
Form of Cerecor Voting Agreement, dated November 1, 2019
(Filed With SEC on November 4, 2019)
-
Form of Officer Voting Agreement, dated November 1, 2019
(Filed With SEC on November 4, 2019)